Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W M Johnson

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2017
All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reportingSally F Barrington, Tom Sulkin, Adam Forbes, et al.
Haematologica|December 7, 2005
Variability of quantitative polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicenter studyAngela J Darby, Stuart Lanham, Pierre Soubeyran, et al.
Oncology Reports|February 22, 2008
BAG-1 inhibits PPARgamma-induced cell death, but not PPARgamma-induced transcription, cell cycle arrest or differentiation in breast cancer cellsSimon J Crabb, Angela Hague, Peter W M Johnson, et al.
Blood|April 26, 2003
Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphomaJamie Honeychurch, Martin J Glennie, Peter W M Johnson, et al.
Drug Discovery Today|August 2, 2015
A collaborative approach to enabling stratified cancer medicine in the UKAlice Tuff-Lacey, Emily Shaw, Rebecca Cummings, et al.
Critical Reviews in Oncology/Hematology|March 21, 2017
Primary mediastinal large B-cell lymphomaMaurizio Martelli, Andrés Ferreri, Alice Di Rocco, et al.
FEBS Letters|October 6, 2009
Short peptides derived from the BAG-1 C-terminus inhibit the interaction between BAG-1 and HSC70 and decrease breast cancer cell growthAdam Sharp, Ramsey I Cutress, Peter W M Johnson, et al.
Cancers|May 13, 2023
Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic StrategiesConstantinos Savva, Ellen Copson, Peter W M Johnson, et al.
Current Medicinal Chemistry|April 16, 2004
Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cellsSara M E Osford, Claire L Dallman, Peter W M Johnson, et al.
British Journal of Haematology|January 26, 2008
Intestinal strictures: a new complication of treatment for primary gastrointestinal diffuse large B-cell lymphomaJonathan P Kerr, Mandy Turner, Margaret Ashton-Key, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2017
All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reportingSally F Barrington, Tom Sulkin, Adam Forbes, et al.
Haematologica|December 7, 2005
Variability of quantitative polymerase chain reaction detection of the bcl-2-IgH translocation in an international multicenter studyAngela J Darby, Stuart Lanham, Pierre Soubeyran, et al.
Oncology Reports|February 22, 2008
BAG-1 inhibits PPARgamma-induced cell death, but not PPARgamma-induced transcription, cell cycle arrest or differentiation in breast cancer cellsSimon J Crabb, Angela Hague, Peter W M Johnson, et al.
Blood|April 26, 2003
Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphomaJamie Honeychurch, Martin J Glennie, Peter W M Johnson, et al.
Drug Discovery Today|August 2, 2015
A collaborative approach to enabling stratified cancer medicine in the UKAlice Tuff-Lacey, Emily Shaw, Rebecca Cummings, et al.
Critical Reviews in Oncology/Hematology|March 21, 2017
Primary mediastinal large B-cell lymphomaMaurizio Martelli, Andrés Ferreri, Alice Di Rocco, et al.
FEBS Letters|October 6, 2009
Short peptides derived from the BAG-1 C-terminus inhibit the interaction between BAG-1 and HSC70 and decrease breast cancer cell growthAdam Sharp, Ramsey I Cutress, Peter W M Johnson, et al.
Cancers|May 13, 2023
Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic StrategiesConstantinos Savva, Ellen Copson, Peter W M Johnson, et al.
Current Medicinal Chemistry|April 16, 2004
Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cellsSara M E Osford, Claire L Dallman, Peter W M Johnson, et al.
British Journal of Haematology|January 26, 2008
Intestinal strictures: a new complication of treatment for primary gastrointestinal diffuse large B-cell lymphomaJonathan P Kerr, Mandy Turner, Margaret Ashton-Key, et al.
Pageof 11